The drug approval tactician
نویسندگان
چکیده
منابع مشابه
Drug approval and drug effectiveness.
Data on the efficacy and safety of psychiatric medicines should form the foundation of evidence-based treatment practices. The US Food and Drug Administration (FDA) reviews such data in determining whether to approve new treatments, and the published literature serves as a repository for evidence on treatment benefits and harms. We describe the FDA review of clinical trials, examining the under...
متن کاملFDA drug approval summaries: oxaliplatin.
The purpose of this report is to summarize information on oxaliplatin, a drug recently approved by the U.S. Food and Drug Administration. Information provided includes regulatory history, study design, efficacy and safety results, and pertinent literature references. A single, multicenter, randomized trial, enrolling 463 patients with metastatic colorectal carcinoma whose disease had recurred o...
متن کاملA Bayesian Tactician
We describe a generative Bayesian model of tactical attacks in strategy games, which can be used both to predict attacks and to take tactical decisions. This model is designed to easily integrate and merge information from other (probabilistic) estimations and heuristics. In particular, it handles uncertainty in enemy units’ positions as well as their probable tech tree. We claim that learning,...
متن کاملRefactoring Proofs with Tactician
Tactician is a tool for refactoring tactic proof scripts for the HOL Light theorem prover. Its core operations are packaging up a series of tactic steps into a compact proof with tactical connectives, and the reverse operation of unravelling compact proofs into interactive steps. This can be useful for novices learning from legacy proof scripts, as well as for experienced users maintaining thei...
متن کاملFDA drug approval summaries: fulvestrant.
Patients with hormone-sensitive breast cancer who have responded to tamoxifen may receive additional benefit from a second endocrine agent following progression or relapse after tamoxifen therapy. Fulvestrant (Faslodex((R)), ICI 182780, AstraZeneca Pharmaceuticals; Wilmington, Delaware) is a selective antagonist of estrogen designed to have no estrogenic effects. Lack of aqueous solubility led ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature Reviews Drug Discovery
سال: 2003
ISSN: 1474-1776,1474-1784
DOI: 10.1038/nrd1195